Marie Antoinette's Pearl Pendant Sells for $36 Million
(Bloomberg) -- A pearl and diamond pendant that once adorned the neck of ill-fated French Queen Marie Antoinette sold for a record 36.4 million Swiss francs ($36 million) at auction on Wednesday in Geneva.
Not seen in public for more than 200 years, the gems belonged to the Bourbon-Parma family, which traces its lineage back to French King Louis XIV. His great, great, great grandson, King Louis XVI, and his wife Marie Antoinette were beheaded in 1793. The queen was able to smuggle some of her jewelry outside France before she died.
The pendant is set with an oval diamond supporting a diamond-bow motif and a drop-shaped pearl. It was suspended from a three strand pearl necklace that was sold separately. Sotheby's said the two pieces comprised part of “the most important royal jewelry collections ever to come to auction.”
After a 14-minute contest, the anonymous bidder paid 18 times the high pre-sale estimate of $2 million. Estimates don't reflect the buyer's premium added to the hammer price of sold objects. The sale dethroned Elizabeth Taylor's 50.6-carat La Peregrina, which sold at Christie's in 2011 for $11.8 million, as the world's most expensive pearl jewel.
Harry Winston paid $50 million for a pink diamond at Christie's on Tuesday, setting a record for price paid per carat for a gem of that hue. Sotheby's will hold a separate jewel auction in Geneva on Thursday.
--With assistance from Corinne Gretler.
To contact the reporter on this story: Frederik Balfour in Hong Kong at fbalfour@bloomberg.net
To contact the editors responsible for this story: Pierre Paulden at ppaulden@bloomberg.net, Katrina Nicholas, Paul Panckhurst
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.